J Walker1, A Sawhney2, C Holm Hansen2, S Ahmed1, P Martin2, S Symeonides3, G Murray4, M Sharpe1. 1. Psychological Medicine Research, University of Oxford Department of Psychiatry, Warneford Hospital, Oxford, UK. 2. Psychological Medicine Research, University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. 3. University of Edinburgh Cancer UK Research Centre, Western General Hospital, Edinburgh, UK. 4. University of Edinburgh Centre for Population Health Sciences, Edinburgh, UK.
Abstract
BACKGROUND: Depression is a leading cause of disease burden worldwide and is especially problematic in people with chronic diseases, including cancer. Although depression can be effectively treated in the general population using antidepressant medication and psychological treatments, these treatments may have different benefits and harms in cancer patients. Previous reviews have not adequately addressed this topic. We therefore aimed to determine which, if any, treatments are effective for patients with diagnoses of both cancer and depression. METHOD: We conducted a systematic review of relevant randomized controlled trials identified through searches of Medline, EMBASE, PsycINFO and The Cochrane Central Register of Controlled Trials (CENTRAL). RESULTS: Seven relatively small trials met the selection criteria. These provided some evidence that antidepressant medication, given alone or in combination with a psychological treatment, may be effective. We found no good evidence for psychological treatments given alone or for any other forms of treatment. CONCLUSIONS: There is very limited evidence from clinical trials to guide the treatment of cancer patients with a diagnosis of depression, especially for psychological treatments. High quality trials of treatments for depression in patients with cancer are urgently needed.
BACKGROUND:Depression is a leading cause of disease burden worldwide and is especially problematic in people with chronic diseases, including cancer. Although depression can be effectively treated in the general population using antidepressant medication and psychological treatments, these treatments may have different benefits and harms in cancerpatients. Previous reviews have not adequately addressed this topic. We therefore aimed to determine which, if any, treatments are effective for patients with diagnoses of both cancer and depression. METHOD: We conducted a systematic review of relevant randomized controlled trials identified through searches of Medline, EMBASE, PsycINFO and The Cochrane Central Register of Controlled Trials (CENTRAL). RESULTS: Seven relatively small trials met the selection criteria. These provided some evidence that antidepressant medication, given alone or in combination with a psychological treatment, may be effective. We found no good evidence for psychological treatments given alone or for any other forms of treatment. CONCLUSIONS: There is very limited evidence from clinical trials to guide the treatment of cancerpatients with a diagnosis of depression, especially for psychological treatments. High quality trials of treatments for depression in patients with cancer are urgently needed.
Authors: Joanne M Shaw; Melanie A Price; Josephine M Clayton; Peter Grimison; Tim Shaw; Nicole Rankin; Phyllis N Butow Journal: Support Care Cancer Date: 2015-04-23 Impact factor: 3.603
Authors: Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee Journal: Clin Exp Otorhinolaryngol Date: 2017-01-03 Impact factor: 3.372
Authors: Alix E Hall; Rob W Sanson-Fisher; Mariko L Carey; Chris Paul; Anna Williamson; Ken Bradstock; H Sharon Campbell Journal: Support Care Cancer Date: 2016-05-31 Impact factor: 3.603
Authors: Kelly E Irwin; Elyse R Park; Lauren E Fields; Amy E Corveleyn; Joseph A Greer; Giselle K Perez; Catherine A Callaway; Jamie M Jacobs; Andrew A Nierenberg; Jennifer S Temel; David P Ryan; William F Pirl Journal: Oncologist Date: 2019-01-29
Authors: Jane Turner; Brian Kelly; David Clarke; Patsy Yates; Sanchia Aranda; Damien Jolley; Andrew Forbes; Suzanne Chambers; Maryanne Hargraves; Lisa Mackenzie Journal: Support Care Cancer Date: 2016-08-17 Impact factor: 3.603
Authors: D R Sullivan; C W Forsberg; L Ganzini; D H Au; M K Gould; D Provenzale; K S Lyons; C G Slatore Journal: Lung Cancer Date: 2016-08-16 Impact factor: 5.705
Authors: Soonhee Roh; Catherine E Burnette; Yeon-Shim Lee; Jarod T Giger; R Turner Goins; Daniel G Petereit; Michael J Lawler; Kyoung Hag Lee Journal: Women Health Date: 2018-11-27
Authors: Michael J Fisch; Fengmin Zhao; Judith Manola; Andrew H Miller; William F Pirl; Lynne I Wagner Journal: Psychooncology Date: 2014-06-14 Impact factor: 3.894